UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Journal of clinical oncology, 2006-10, Vol.24 (29), p.4738-4745

2006

Volltextzugriff (PDF)

Metastatic uveal melanoma therapy: current options

International ophthalmology clinics, 2006, Vol.46 (1), p.151-166

Bedikian, Agop Y

2006

Volltextzugriff (PDF)

Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'

Melanoma research, 2014-06, Vol.24 (3), p.237-243

2014

Volltextzugriff (PDF)

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

European journal of cancer (1990), 2009-07, Vol.45 (10), p.1807-1814

2009

Volltextzugriff (PDF)

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

Oncotarget, 2015-05, Vol.6 (14), p.12809-12821

2015

Volltextzugriff (PDF)

Uveal melanoma in the first 4 decades of life

Southern medical journal (Birmingham, Ala.), 2015-03, Vol.108 (3), p.158-163

2015

Volltextzugriff (PDF)

A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma

Melanoma research, 2010-06, Vol.20 (3), p.218-226

2010

Volltextzugriff (PDF)

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

Cancers, 2019-01, Vol.11 (2), p.152

2019

Volltextzugriff (PDF)

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

Journal of clinical oncology, 2002-04, Vol.20 (8), p.2045-2052

2002

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Clinical cancer research, 2002-05, Vol.8 (5), p.1038-1044

2002

Volltextzugriff (PDF)

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

Journal of translational medicine, 2010-01, Vol.8 (1), p.9-9, Article 9

2010

Volltextzugriff (PDF)

Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma

American journal of clinical oncology, 2011-12, Vol.34 (6), p.603-610

2011

Volltextzugriff (PDF)

Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver

American journal of clinical oncology, 2018-11, Vol.41 (11), p.1132-1136

2018

Volltextzugriff (PDF)

A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2099-2107

2014

Volltextzugriff (PDF)

Allovectin-7 therapy in metastatic melanoma

Expert opinion on biological therapy, 2008-06, Vol.8 (6), p.839-844

2008

Volltextzugriff (PDF)

A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma

Melanoma research, 2016-12, Vol.26 (6), p.604-608

2016

Volltextzugriff (PDF)

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma

Melanoma research, 2010-12, Vol.20 (6), p.507-510

2010

Volltextzugriff (PDF)

Malignant melanoma in teenagers and young adults

Journal of pediatric hematology/oncology, 2014-10, Vol.36 (7), p.552-558

2014

Volltextzugriff (PDF)

Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma

Clinical cancer research, 2012-02, Vol.18 (4), p.1120-1128

2012

Volltextzugriff (PDF)

Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib

The Journal of clinical and aesthetic dermatology, 2013-05, Vol.6 (5), p.27-37

2013

Volltextzugriff (PDF)

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Melanoma research, 2012-08, Vol.22 (4), p.294-301

2012

Volltextzugriff (PDF)

Biochemotherapy in patients with advanced head and neck mucosal melanoma

Head & neck, 2008-12, Vol.30 (12), p.1592-1598

2008

Volltextzugriff (PDF)

Delayed Systemic Recurrence of Uveal Melanoma

American journal of clinical oncology, 2013-10, Vol.36 (5), p.443-449

2013

Volltextzugriff (PDF)

High-dose Vincristine Sulfate Liposome Injection (Marqibo) Is Not Associated With Clinically Meaningful Hematologic Toxicity

Clinical lymphoma, myeloma and leukemia, 2014-06, Vol.14 (3), p.197-202

2014

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(150)

Sprache

Englisch
(150)
Japanisch
(10)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(108)
Life Sciences & Biomedicine
(108)
Science & Technology
(108)
Male
(89)
Oncology
(88)
Female
(87)
Middle Aged
(85)
Adult
(80)
Aged
(73)
Melanoma - Drug Therapy
(47)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Melanoma
(38)
Dermatology
(34)
Melanoma - Pathology
(32)
Treatment Outcome
(31)
Melanoma - Secondary
(29)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Neoplasm Metastasis
(28)
Pharmacology. Drug Treatments
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Metastatic uveal melanoma therapy: current options

Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

Uveal melanoma in the first 4 decades of life

A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized Trial

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma

Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver

A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma

Allovectin-7 therapy in metastatic melanoma

A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma

Malignant melanoma in teenagers and young adults

Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma

Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

Biochemotherapy in patients with advanced head and neck mucosal melanoma

Delayed Systemic Recurrence of Uveal Melanoma

High-dose Vincristine Sulfate Liposome Injection (Marqibo) Is Not Associated With Clinically Meaningful Hematologic Toxicity

Suchergebnisse filtern